ImageneBio Inc Stock Analysis & AI Score
ImageneBio Inc (IMA) has an ST Score of 43.0 (C), driven by its Financial Strength (A) and held back by its Forecast (D). Analysts rate it Buy with a $1.33 price target (-71.5% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
ImageneBio Inc (IMA) has an ST Score of 43.0 (C), driven by its Financial Strength (A) and held back by its Forecast (D). Analysts rate it Buy with a $1.33 price target (-71.5% downside).
- Strongest
- Financial StrengthA
- Weakest
- ForecastD
All factor grades
- Financial StrengthA
- ValuationB
- ProfitabilityB-
- GrowthB-
- MomentumD
- ForecastD
- Piotroski1/9
Contact
IMA stock: frequently asked questions
What is IMA's ST Score?
ImageneBio Inc (IMA) has an ST Score of 43.0 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IMA a buy, hold, or sell?
Analysts rate IMA a Buy, with a price target of $1.33 (-71.5% vs the current price). Our ST Score grades it C (43.0/100). The ST Score is a data-driven signal, not a recommendation.
What are IMA's factor grades?
Valuation B, Profitability B-, Financial Strength A, Momentum D, Growth B-, Forecast D.
What is IMA's valuation grade?
ImageneBio Inc (IMA) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IMA's growth grade?
ImageneBio Inc (IMA) earns a growth grade of B-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IMA's profitability grade?
ImageneBio Inc (IMA) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IMA's financial strength grade?
ImageneBio Inc (IMA) earns a financial strength grade of A, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IMA?
The average analyst price target for ImageneBio Inc (IMA) is $1.33 from 5 analysts, which is -71.5% versus the recent price of $4.66.
What is IMA's Piotroski score?
ImageneBio Inc (IMA) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.